{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:50:30Z","timestamp":1771030230263,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CURR MED SCI"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s11596-021-2458-3","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T11:03:16Z","timestamp":1637146996000},"page":"1205-1213","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cyr61 Alleviates Cholangitis by Inhibiting Cytotoxic Effects of CD8+ T Cells on Biliary Epithelial Cells"],"prefix":"10.1007","volume":"41","author":[{"given":"Tiao-chun","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin-ling","family":"Ju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-guo","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-jun","family":"She","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao-lian","family":"Bian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,17]]},"reference":[{"issue":"1","key":"2458_CR1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41395-018-0390-3","volume":"114","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM, Bernstein D, Shiffman ML, et al. Diagnosis and Management of Primary Biliary Cholangitis. Am J Gastroenterol, 2019,114(1):48\u201363","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"2458_CR2","doi-asserted-by":"publisher","first-page":"10 269","DOI":"10.1096\/fj.201802606R","volume":"33","author":"L Kennedy","year":"2019","unstructured":"Kennedy L, Francis H, Invernizzi P, et al. Secretin\/ secretin receptor signaling mediates biliary damage and liver fibrosis in early-stage primary biliary cholangitis. FASEB J, 2019,33(9): 10 269\u201310 279","journal-title":"FASEB J"},{"key":"2458_CR3","doi-asserted-by":"publisher","first-page":"102328","DOI":"10.1016\/j.jaut.2019.102328","volume":"105","author":"BT Beretta-Piccoli","year":"2019","unstructured":"Beretta-Piccoli BT, Mieli-Vergani G, Vergani D, et al. The challenges of primary biliary cholangitis: What is new and what needs to be done. J Autoimmun, 2019, 105:102328","journal-title":"J Autoimmun"},{"issue":"6","key":"2458_CR4","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1002\/hep.30552","volume":"70","author":"A Honda","year":"2019","unstructured":"Honda A, Tanaka A, Kaneko T, et al. Bezafibrate Improves GLOBE and UK-PBC Scores and Long-Term Outcomes in Patients With Primary Biliary Cholangitis. Hepatology (Baltimore, Md.), 2019,70(6):2035\u20132046","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"2458_CR5","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1146\/annurev-pathol-020712-164014","volume":"8","author":"GM Hirschfield","year":"2013","unstructured":"Hirschfield GM, Gershwin ME. The immunobiology and pathophysiology of primary biliary cirrhosis. Annu Rev Pathol, 2013,8:303\u2013330","journal-title":"Annu Rev Pathol"},{"issue":"7","key":"2458_CR6","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1056\/NEJMoa1509840","volume":"375","author":"F Nevens","year":"2016","unstructured":"Nevens F, Andreone P, Mazzella G, et al. A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis. N Engl J Med, 2016,375(7):631\u2013643","journal-title":"N Engl J Med"},{"issue":"7","key":"2458_CR7","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1007\/s00535-016-1223-z","volume":"51","author":"A Tanaka","year":"2016","unstructured":"Tanaka A, Takikawa H, Mochida S, et al. Changing Nomenclature for PBC from \u201cPrimary Biliary Cirrhosis\u201d to \u201cPrimary Biliary Cholangitis\u201d. J Gastroenterol, 2016, 51(7):748\u2013749","journal-title":"J Gastroenterol"},{"issue":"1","key":"2458_CR8","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.1038\/s41598-020-60138-8","volume":"10","author":"L Ju","year":"2020","unstructured":"Ju L, Sun Y, Xue H, et al. CCN1 promotes hepatic steatosis and inflammation in non-alcoholic steatohepatitis. Sci Rep, 2020,10(1):3201","journal-title":"Sci Rep"},{"issue":"4","key":"2458_CR9","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1002\/hep.24526","volume":"54","author":"M Tsuda","year":"2011","unstructured":"Tsuda M, Ambrosini YM, Zhang W, et al. Fine phenotypic and functional characterization of effector cluster of differentiation 8 positive T cells in human patients with primary biliary cirrhosis. Hepatology (Baltimore, Md.), 2011,54(4):1293\u20131302","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"1","key":"2458_CR10","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s12079-018-0458-2","volume":"12","author":"SM Twigg","year":"2018","unstructured":"Twigg SM. Regulation and bioactivity of the CCN family of genes and proteins in obesity and diabetes. J Cell Commun Signal, 2018,12(1):359\u2013368","journal-title":"J Cell Commun Signal"},{"issue":"1","key":"2458_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3892\/mmr.2015.4516","volume":"17","author":"R Yang","year":"2018","unstructured":"Yang R, Chen Y, Chen D. Biological functions and role of CCN1\/Cyr61 in embryogenesis and tumorigenesis in the female reproductive system (Review). Mol Med Rep, 2018,17(1):3\u201310","journal-title":"Mol Med Rep"},{"issue":"1","key":"2458_CR12","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/jcp.24690","volume":"230","author":"YS Park","year":"2015","unstructured":"Park YS, Hwang S, Jin YM, et al. CCN1 secreted by tonsil-derived mesenchymal stem cells promotes endothelial cell angiogenesis via integrin alphav beta3 and AMPK. J Cell Physiol, 2015,230(1):140\u2013149","journal-title":"J Cell Physiol"},{"issue":"12","key":"2458_CR13","doi-asserted-by":"publisher","first-page":"4457","DOI":"10.1182\/blood.V99.12.4457","volume":"99","author":"JM Schober","year":"2002","unstructured":"Schober JM, Chen N, Grzeszkiewicz TM, et al. Identification of integrin alpha(M)beta(2) as an adhesion receptor on peripheral blood monocytes for Cyr61 (CCN1) and connective tissue growth factor (CCN2): immediate-early gene products expressed in atherosclerotic lesions. Blood, 2002,99(12):4457\u20134465","journal-title":"Blood"},{"issue":"6","key":"2458_CR14","doi-asserted-by":"publisher","first-page":"3096","DOI":"10.1096\/fj.201700830RR","volume":"32","author":"Y Yang","year":"2018","unstructured":"Yang Y, Qi Q, Wang Y, et al. Cysteine-rich protein 61 regulates adipocyte differentiation from mesenchymal stem cells through mammalian target of rapamycin complex 1 and canonical Wnt signaling. FASEB J, 2018,32(6):3096\u20133107","journal-title":"FASEB J"},{"issue":"2","key":"2458_CR15","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/mi.2014.62","volume":"8","author":"HG Moon","year":"2015","unstructured":"Moon HG, Qin Z, Quan T, et al. Matrix protein CCN1 induced by bacterial DNA and CpG ODN limits lung inflammation and contributes to innate immune homeostasis. Mucosal Immunol, 2015,8(2):243\u2013253","journal-title":"Mucosal Immunol"},{"issue":"1","key":"2458_CR16","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13075-019-1906-y","volume":"21","author":"Y Fan","year":"2019","unstructured":"Fan Y, Yang X, Zhao J, et al. Cysteine-rich 61 (Cyr61): a biomarker reflecting disease activity in rheumatoid arthritis. Arthritis Res Ther, 2019,21(1):123","journal-title":"Arthritis Res Ther"},{"issue":"19","key":"2458_CR17","doi-asserted-by":"publisher","first-page":"e834","DOI":"10.1097\/MD.0000000000000834","volume":"94","author":"J Lin","year":"2015","unstructured":"Lin J, Li N, Chen H, et al. Serum Cyr61 is associated with clinical disease activity and inflammation in patients with systemic lupus erythematosus. Medicine, 2015,94(19):e834","journal-title":"Medicine"},{"issue":"7","key":"2458_CR18","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1080\/09273948.2017.1319960","volume":"26","author":"YJ Woo","year":"2018","unstructured":"Woo YJ, Seo Y, Kim JJ, et al. Serum CYR61 Is Associated with Disease Activity in Graves\u2019 Orbitopathy. Ocul Immunol Inflamm, 2018,26(7):1094\u20131100","journal-title":"Ocul Immunol Inflamm"},{"issue":"6","key":"2458_CR19","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/mi.2015.19","volume":"8","author":"JS Choi","year":"2015","unstructured":"Choi JS, Kim KH, Lau LF. The matricellular protein CCN1 promotes mucosal healing in murine colitis through IL-6. Mucosal Immunol, 2015,8(6):1285\u20131296","journal-title":"Mucosal Immunol"},{"issue":"18","key":"2458_CR20","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1007\/s00018-012-0981-x","volume":"69","author":"M L\u00f6bel","year":"2012","unstructured":"L\u00f6bel M, Bauer S, Meisel C, et al. CCN1: a novel inflammation-regulated biphasic immune cell migration modulator. Cell Mol Life Sci, 2012,69(18):3101\u20133113","journal-title":"Cell Mol Life Sci"},{"issue":"25","key":"2458_CR21","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1161\/CIRCULATIONAHA.110.945261","volume":"122","author":"M Rother","year":"2010","unstructured":"Rother M, Krohn S, Kania G, et al. Matricellular signaling molecule CCN1 attenuates experimental autoimmune myocarditis by acting as a novel immune cell migration modulator. Circulation, 2010,122(25):2688\u20132698","journal-title":"Circulation"},{"issue":"1","key":"2458_CR22","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/hep.29418","volume":"67","author":"H Zhang","year":"2018","unstructured":"Zhang H, Lian M, Zhang J, et al. A functional characteristic of cysteine-rich protein 61: Modulation of myeloid-derived suppressor cells in liver inflammation. Hepatology (Baltimore, Md.), 2018,67(1):232\u2013246","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"2","key":"2458_CR23","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1002\/hep.22390","volume":"48","author":"K Wakabayashi","year":"2008","unstructured":"Wakabayashi K, Lian ZX, Leung PS, et al. Loss of tolerance in C57BL\/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease. Hepatology (Baltimore, Md.), 2008,48(2):531\u2013540","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"5","key":"2458_CR24","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1002\/hep.23132","volume":"50","author":"K Yoshida","year":"2009","unstructured":"Yoshida K, Yang GX, Zhang W, et al. Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor beta receptor type II mice. Hepatology (Baltimore, Md.), 2009,50(5):1494\u20131500","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"8","key":"2458_CR25","doi-asserted-by":"publisher","first-page":"L759","DOI":"10.1152\/ajplung.00190.2014","volume":"308","author":"S Grazioli","year":"2015","unstructured":"Grazioli S, Gil S, An D, et al. CYR61 (CCN1) overexpression induces lung injury in mice. Am J Physiol Lung Cell Mol Physiol, 2015,308(8):L759\u2013765","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"2","key":"2458_CR26","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.clim.2009.09.007","volume":"134","author":"K Migita","year":"2010","unstructured":"Migita K, Ilyassova B, Kovzel EF, et al. Serum BAFF and APRIL levels in patients with PBC. Clinical immunology (Orlando, Fla.), 2010,134(2):217\u2013225","journal-title":"Clinical immunology (Orlando, Fla.)"},{"issue":"6","key":"2458_CR27","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1042\/CS20181123","volume":"133","author":"WT Ma","year":"2019","unstructured":"Ma WT, Chen DK. Immunological abnormalities in patients with primary biliary cholangitis. Clin Sci (Lond), 2019,133(6):741\u2013760","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"2458_CR28","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.1038\/s41598-020-60138-8","volume":"10","author":"L Ju","year":"2020","unstructured":"Ju L, Sun Y, Xue H, et al. CCN1 promotes hepatic steatosis and inflammation in non-alcoholic steatohepatitis. Sci Rep, 2020,10(1):3201","journal-title":"Sci Rep"},{"issue":"1","key":"2458_CR29","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1194\/jlr.M026013","volume":"54","author":"Z Bian","year":"2013","unstructured":"Bian Z, Peng Y, You Z, et al. CCN1 expression in hepatocytes contributes to macrophage infiltration in nonalcoholic fatty liver disease in mice. J Lipid Res, 2013,54(1):44\u201354","journal-title":"J Lipid Res"},{"issue":"3","key":"2458_CR30","first-page":"1518","volume":"41","author":"ZQ Li","year":"2018","unstructured":"Li ZQ, Wu WR, Zhao C, et al. CCN1\/Cyr61 enhances the function of hepatic stellate cells in promoting the progression of hepatocellular carcinoma. Int J Mol Med, 2018,41(3):1518\u20131528","journal-title":"Int J Mol Med"},{"issue":"5","key":"2458_CR31","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1172\/JCI79327","volume":"125","author":"KH Kim","year":"2015","unstructured":"Kim KH, Chen CC, Alpini G, et al. CCN1 induces hepatic ductular reaction through integrin \u03b1v\u03b25-mediated activation of NF-\u03baB. J Clin Invest, 2015,125(5):1886\u20131900","journal-title":"J Clin Invest"},{"issue":"3","key":"2458_CR32","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jaut.2012.05.022","volume":"39","author":"Z You","year":"2012","unstructured":"You Z, Wang Q, Bian Z, et al. The immunopathology of liver granulomas in primary biliary cirrhosis. J Autoimmun, 2012,39(3):216\u2013221","journal-title":"J Autoimmun"},{"issue":"40","key":"2458_CR33","doi-asserted-by":"publisher","first-page":"16 735","DOI":"10.1073\/pnas.1112251108","volume":"108","author":"V Benseler","year":"2011","unstructured":"Benseler V, Warren A, Vo M, et al. Hepatocyte entry leads to degradation of autoreactive CD8 T cells. Proc Natl Acad Sci USA, 2011,108(40):16 735\u201316 740","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"2458_CR34","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/cmi.2017.149","volume":"15","author":"W Zhang","year":"2018","unstructured":"Zhang W, Zhang R, Zhang J, et al. Proteomic analysis reveals distinctive protein profiles involved in CD8 T cell-mediated murine autoimmune cholangitis. Cell Mol Immunol, 2018,15(8):756\u2013767","journal-title":"Cell Mol Immunol"},{"issue":"6","key":"2458_CR35","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1002\/hep.22226","volume":"47","author":"GX Yang","year":"2008","unstructured":"Yang GX, Lian ZX, Chuang YH, et al. Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice. Hepatology, 2008,47(6):1974\u20131982","journal-title":"Hepatology"}],"container-title":["Current Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-021-2458-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11596-021-2458-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-021-2458-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T13:33:59Z","timestamp":1650375239000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11596-021-2458-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,17]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2458"],"URL":"https:\/\/doi.org\/10.1007\/s11596-021-2458-3","relation":{},"ISSN":["2096-5230","2523-899X"],"issn-type":[{"value":"2096-5230","type":"print"},{"value":"2523-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,17]]},"assertion":[{"value":"5 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}